Brief: Gensight Biologics Launches Capital Increase Of Around EUR 25 Mln

Gensight Biologics SA

21/10/2020 17:37

Oct 21 (Reuters) - Gensight Biologics SA  SIGHT.PA :
    * GENSIGHT BIOLOGICS LAUNCHES A CAPITAL INCREASE OF
APPROXIMATELY
€25 MILLION BY MEANS OF AN ACCELERATED BOOKBUILDING PROCESS
    * NEW SHARES WILL BE ISSUED THROUGH A SHARE CAPITAL INCREASE
WITHOUT SHAREHOLDERS’ PREFERENTIAL SUBSCRIPTION RIGHTS PURSUANT
TO 19TH AND 25TH RESOLUTIONS OF AGM ON APRIL 29, 2020
    * INTENDS TO USE THE NET PROCEEDS FROM THE RESERVED OFFERING
TO
ACTIVELY PREPARE THE COMMERCIAL LAUNCH OF LUMEVOQ®
    * SETTLEMENT OF RESERVED OFFERING AND ADMISSION OF THE NEW
SHARES
TO TRADING ON EURONEXT PARIS ARE SCHEDULED FOR OCTOBER 26, 2020

Source text for Eikon:  ID:nNDL3pCxnX 
Further company coverage:  SIGHT.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))